# Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction

> **NCT05168787** · — · COMPLETED · sponsor: **Methodist Health System** · enrollment: 6558 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** sacubitril/valsartan

## Key facts

- **NCT ID:** NCT05168787
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-13
- **Primary completion:** 2025-07-08
- **Final completion:** 2025-07-08
- **Target enrollment:** 6558 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05168787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05168787, "Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05168787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*